Launch week offerEnds in00h00m00s

annual Promonthly Pro

Béatrice NAWROCKI-RABY

France

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Articles (12)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (10)

isabelle hininger-favier

FRANCE

View details

Sylvie Coscoy

Centre National de la Recherche Scientifique (CNRS)

FRANCE

View details

Julie Gavard

CNRS

FRANCE

View details

Claire CALMEL

INSERM

FRANCE

View details

florence franconi

Université d'Angers

FRANCE

View details

Uwe Schlattner

Université Grenoble Alpes

FRANCE

View details

TERESITA PADILLA-BENAVIDES

Assistant Professor

Wesleyan University

UNITED STATES

View details

valerian dormoy

Professor Associate

Université de Reims Champagne-Ardenne

FRANCE

View details

Catherine Guette

Université d'Angers

FRANCE

View details

Julien Ancel

Dr (pneumology - oncologist)

Institut Curie

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Béatrice NAWROCKI-RABY

Research Interests

Make your next move.

Explore related searches

Articles (12)

AXL expression to predict resistance to immunotherapy in metastatic non-small cell lung cancer

LRP1 involvement in FHIT-regulated HER2 signaling in non-small cell lung cancer.

HER2 Alterations in Non-Small Cell Lung Cancer: Biologico-Clinical Consequences and Interest in Therapeutic Strategies

Soluble biomarkers to predict clinical outcomes in non-small cell lung cancer treated by immune checkpoints inhibitors.

Transcriptomic FHIT<sup>low</sup>/pHER2<sup>high</sup> signature as a predictive factor of outcome and immunotherapy response in non-small cell lung cancer.

The mitochondrially-localized nucleoside diphosphate kinase D (NME4) is a novel metastasis suppressor

Loss of the Metastasis Suppressor NME1, But Not of Its Highly Related Isoform NME2, Induces a Hybrid Epithelial–Mesenchymal State in Cancer Cells

ZO-1 Intracellular Localization Organizes Immune Response in Non-Small Cell Lung Cancer.

Hypoxia in Lung Cancer Management: A Translational Approach

Clinical Impact of the Epithelial-Mesenchymal Transition in Lung Cancer as a Biomarker Assisting in Therapeutic Decisions

S100A4 is a Biomarker of Tumorigenesis, EMT, Invasion, and Colonization of Host Organs in Experimental Malignant Mesothelioma.

FHITlow /pHER2high signature in non-small cell lung cancer is predictive of anti-HER2 molecule efficacy.

Collaborators (10)

isabelle hininger-favier

Sylvie Coscoy

Julie Gavard

Claire CALMEL

florence franconi

Uwe Schlattner

TERESITA PADILLA-BENAVIDES

valerian dormoy

Catherine Guette

Julien Ancel

Make your next move.